Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities
Yong Zhang; Lanbo Liu; Jie Ma; Shihui XiaShow moreShow less
Department of Cardiothoracic Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, No. 136, Jingzhou Street, Xiangcheng District, 441106 Xiangyang, Hubei, ChinaShow moreShow less
A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome
Jurjen M. Ruben; Charlotte M. Mousset; Dorien van de Berg; Kim Hofman; Milon de Jong; Patricia Brouwer; Sanne Graeve; Victoria Iglesias-Guimarais; Pauline M. van Helden; Anton E.P. Adang; Rob C. Roovers; Hans J. van der VlietShow moreShow less
Department of Medical Oncology, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, 1081 HV, the Netherlands; LAVA Therapeutics N.V, Utrecht, the Netherlands; Engager BIO B.V, Amstelveen, the NetherlandsShow moreShow less
Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia
Gang Chen; Jing Xu; Xiaoyu He; Yixin Yan; Linhui Hu; Zhenjiang LiShow moreShow less
Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaShow moreShow less
Development of bi-functional hybrid IgGA antibodies for enhancing cancer immunotherapy
Xiuyun Li; Vladislav Rybchenko; Naida Mamaeva; Jingyan Wang; Dmitry Dolgikh; Baohang Lin; Victoria ArgentovaShow moreShow less
Faculty of Biology, Shenzhen MSU-BIT University, Shenzhen 518172, China; Department of Thyroid, Breast and Vascular Surgery, Longgang Central Hospital of Shenzhen, Shenzhen 518000, China; Faculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry (IBKh), Russian Academy of Sciences, Moscow 117997, RussiaShow moreShow less
The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus
David S. Pisetsky; Yuankang Zhao; Matthew Engelhard; Amanda Eudy; Philip Tedeschi; Tyler O'Malley; Roberta Vezza Alexander; Megan Clowse; Lisa Criscione-Schreiber; Jayanth Doss; Mithu Maheswaranathan; Rebecca Sadun; Kai Sun; Nathaniel Harris; Jennifer RogersShow moreShow less
Duke University School of Medicine, Department of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA; Duke University School of Medicine, Department of Biostatistics & Bioinformatics, Durham, NC, USA; Immunovant, Inc., New York, NY, USA; Exagen, Inc., Vista, CA, USAShow moreShow less
TIM-3 as a therapeutic target in anaplastic thyroid carcinoma: Preclinical and transcriptomic evidence supporting a new immunotherapy avenue
Monikongkona Boruah; Riyaz Ahmad Mir; Sameer Rastogi; Kapil Sikka; Shipra AgarwalShow moreShow less
Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaShow moreShow less
FAQ
How long does CLINICAL IMMUNOLOGY take to review a manuscript?
As of 2026-11-14, CrushSCI has 15 complete review records for CLINICAL IMMUNOLOGY. The fastest paper went from submission to acceptance in 30 days (A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome, received 2026-09-22, accepted 2026-10-22); the slowest took 201 days. The average is 97.3 days and the median is 83 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
